Ardelyx, Inc. (ARDX)Healthcare | Biotechnology | Waltham, United States | NasdaqGM
5.96 USD
-0.34
(-5.397%) ⇩
(April 21, 2026, 4 p.m.
EDT)
After hours: 6.01 +0.05 (0.839%) ⇧ (April 21, 2026, 5:09 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ★★★☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:30 p.m. EDT
Despite a 'Strong Buy' analyst consensus and solid 9-month revenue growth, the intraday technicals and options flow are screaming bearish protection. The massive April put Book (especially the deep OTM 4.0 strike) indicates a 'below the trend' setup and risk aversion ahead of the April 30 earnings release. Unless staged by� earnings surprise aligns with the $16+ analyst price targets, the secondary market appears to be priced in a downside event or continued volatility rather than an immediate pop. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.215335 |
| AutoETS | 0.216548 |
| AutoARIMA | 0.216705 |
| MSTL | 0.245729 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 49% |
| H-stat | 4.61 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.350 |
| Excess Kurtosis | -0.63 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 140.061 |
| Revenue per Share | 1.69 |
| Market Cap | 1,461,674,624 |
| Forward P/E | 11.33 |
| Beta | 0.66 |
| Profit Margins | -15.12% |
| Website | https://www.ardelyx.com |
As of April 18, 2026, 11:30 p.m. EDT: Options sentiment shows distinct bearish skew in the short term (April/May 2026). Out-of-the-money (OTM) put volume (268) significantly exceeds OTM call volume (236) for the immediate April expiration, driven by massive Open Interest (OI) at the 4.0 strike (9x total put volume). OTM Call OI at the 7.0 strike is the highest among calls, but it represents only 46% of the bearish OI. The setup suggests speculators are hedging a potential downside break below current prices ($6.45) more aggressively than betting on immediate upside. For longer tenors (Oct 2026+), OI splits more evenly (OTM calls favored over 6-month horizon), suggesting a 6-12 month bullish resolution, but short-term theta decay likely incentivizes selling volatility and protecting downside near the earnings print.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.3097713 |
| Address1 | 400 Fifth Avenue |
| Address2 | Suite 210 |
| All Time High | 35.48 |
| All Time Low | 0.49 |
| Ask | 7.61 |
| Ask Size | 2 |
| Audit Risk | 8 |
| Average Analyst Rating | 1.1 - Strong Buy |
| Average Daily Volume10 Day | 2,915,730 |
| Average Daily Volume3 Month | 3,605,514 |
| Average Volume | 3,605,514 |
| Average Volume10Days | 2,915,730 |
| Beta | 0.657 |
| Bid | 4.5 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | 0.683 |
| City | Waltham |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.96 |
| Current Ratio | 4.315 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 6.37 |
| Day Low | 5.885 |
| Debt To Equity | 140.061 |
| Display Name | Ardelyx |
| Earnings Call Timestamp End | 1,777,581,000 |
| Earnings Call Timestamp Start | 1,777,581,000 |
| Earnings Timestamp | 1,777,579,200 |
| Earnings Timestamp End | 1,777,579,200 |
| Earnings Timestamp Start | 1,777,579,200 |
| Ebitda | -37,918,000 |
| Ebitda Margins | -0.09309 |
| Enterprise To Ebitda | -39.934 |
| Enterprise To Revenue | 3.717 |
| Enterprise Value | 1,514,199,808 |
| Eps Current Year | 0.01269 |
| Eps Forward | 0.52611 |
| Eps Trailing Twelve Months | -0.26 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 6.2004 |
| Fifty Day Average Change | -0.24039984 |
| Fifty Day Average Change Percent | -0.038771667 |
| Fifty Two Week Change Percent | 30.97713 |
| Fifty Two Week High | 8.4 |
| Fifty Two Week High Change | -2.4399996 |
| Fifty Two Week High Change Percent | -0.29047614 |
| Fifty Two Week Low | 3.21 |
| Fifty Two Week Low Change | 2.75 |
| Fifty Two Week Low Change Percent | 0.8566978 |
| Fifty Two Week Range | 3.21 - 8.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,403,184,600,000 |
| Float Shares | 222,581,660 |
| Forward Eps | 0.52611 |
| Forward P E | 11.328429 |
| Free Cashflow | 6,751,625 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 489 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.72733 |
| Gross Profits | 296,256,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0304 |
| Held Percent Institutions | 0.69598997 |
| Implied Shares Outstanding | 245,247,427 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts. |
| Long Name | Ardelyx, Inc. |
| Market | us_market |
| Market Cap | 1,461,674,624 |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_58915635 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -61,599,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,545,058,790 |
| Number Of Analyst Opinions | 10 |
| Open | 6.33 |
| Operating Cashflow | -42,483,000 |
| Operating Margins | 0.04072 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 510 745 1700 |
| Post Market Change | 0.05000019 |
| Post Market Change Percent | 0.83892936 |
| Post Market Price | 6.01 |
| Post Market Time | 1,776,805,760 |
| Previous Close | 6.3 |
| Price Eps Current Year | 469.66113 |
| Price Hint | 2 |
| Price To Book | 8.726208 |
| Price To Sales Trailing12 Months | 3.5885167 |
| Profit Margins | -0.15123 |
| Quick Ratio | 3.798 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.09091 |
| Region | US |
| Regular Market Change | -0.34000015 |
| Regular Market Change Percent | -5.3968277 |
| Regular Market Day High | 6.37 |
| Regular Market Day Low | 5.885 |
| Regular Market Day Range | 5.885 - 6.37 |
| Regular Market Open | 6.33 |
| Regular Market Previous Close | 6.3 |
| Regular Market Price | 5.96 |
| Regular Market Time | 1,776,801,601 |
| Regular Market Volume | 3,961,810 |
| Return On Assets | -0.054640003 |
| Return On Equity | -0.36209 |
| Revenue Growth | 0.078 |
| Revenue Per Share | 1.69 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 245,247,427 |
| Shares Percent Shares Out | 0.099700004 |
| Shares Short | 24,462,758 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 21,868,223 |
| Short Name | Ardelyx, Inc. |
| Short Percent Of Float | 0.1126 |
| Short Ratio | 7.43 |
| Source Interval | 15 |
| State | MA |
| Symbol | ARDX |
| Target High Price | 19.0 |
| Target Low Price | 13.0 |
| Target Mean Price | 16.1 |
| Target Median Price | 16.5 |
| Total Cash | 264,688,992 |
| Total Cash Per Share | 1.079 |
| Total Debt | 233,830,000 |
| Total Revenue | 407,320,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.26 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.899675 |
| Two Hundred Day Average Change | 0.060325146 |
| Two Hundred Day Average Change Percent | 0.010225165 |
| Type Disp | Equity |
| Volume | 3,961,810 |
| Website | https://www.ardelyx.com |
| Zip | 2,451 |